associate editors Drs. John D. Reveille (USA), Graciela Alarcon (USA), and Zhanguo Li (China) who were chosen for their proven academic success and expertise in their respective disciplines. Our Associate Editor team reflects the international community of ILAR.
The aim of the editorial board is for Clinical Rheumatology to reflect the field of rheumatology in its wider aspects. Hence, Clinical Rheumatology aims to cover and publish all the recent and established developments in clinical and experimental research as well as the management and evaluation of diagnostic and treatment procedures linked with the inflammatory, immunologic, metabolic, genetic, and degenerative aspects of rheumatic disorders.
Clinical Rheumatology is committed to publish the most relevant, original, and practical articles related to our specialty. And as already mentioned, it will continue to have a strong emphasis on clinical aspects, but it is our hope to be able to expand into more basic research in the not too distant future and eventually find a balance that will be attractive to both clinicians and basic researchers.
Original publications, short communications, editorials, outstanding imaging studies, and reviews in relation to these topics will be accepted for publication. Letters to the editor are welcome as enhancement to discussions. Case reports are no longer accepted, but instead, authors are invited to submit a Case-Based Review: a case report of extreme clinical interest incorporating a mini literature review in an area of new knowledge. Articles in languages other than English may be submitted but will be translated into English at the expense of the authors if accepted.
Both basic and clinical rheumatology has expanded at a rapid pace in recent years, and it is our intention to bring these new developments to our rheumatology community in a timely fashion. Clinical Rheumatology is in a position to be the bearer of this new information and herald innovative ideas and changes in our field. The impact of this journal will continue to increase with the involvement of each and every one of you contributing original and novel ideas in our field.
